Clinical trial · Observational
Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer
NCT01706809CI-TRIAL-00013670unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rectal Cancer | Malignant Rectal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood sampels from vena rectalis superior and vena cubiti | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Biomarkeres
- interventionNames
- Other: blood sampels from vena rectalis superior and vena cubiti
Primary outcomes (1)
- measure
- The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.
- timeFrame
- after the study is complete
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histological verified cancer * The cancer must be located in rectum maximum of 15 cm. * Age above 18 Exclusion Criteria: * Disseminated cancer * Perioperative radio-chemotherapy * Laparoscopy surgery
References
Publications (0)
Data not yet available
No reference posted for this study.